

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 9.03519327 |
| 2 | urate metabolic process (GO:0046415) | 8.74373676 |
| 3 | drug transport (GO:0015893) | 8.09356549 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.07251080 |
| 5 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.90780207 |
| 6 | regulation of guanylate cyclase activity (GO:0031282) | 7.55755120 |
| 7 | organic cation transport (GO:0015695) | 7.51157334 |
| 8 | lysine catabolic process (GO:0006554) | 7.39138967 |
| 9 | lysine metabolic process (GO:0006553) | 7.39138967 |
| 10 | drug catabolic process (GO:0042737) | 7.18762598 |
| 11 | phosphate ion transport (GO:0006817) | 6.92555534 |
| 12 | vitamin D metabolic process (GO:0042359) | 6.81529224 |
| 13 | epoxygenase P450 pathway (GO:0019373) | 6.56122444 |
| 14 | cysteine metabolic process (GO:0006534) | 6.26534262 |
| 15 | modified amino acid transport (GO:0072337) | 6.23206529 |
| 16 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.22826815 |
| 17 | exogenous drug catabolic process (GO:0042738) | 6.13598028 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.85030851 |
| 19 | phosphate ion transmembrane transport (GO:0035435) | 5.78288028 |
| 20 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.77549712 |
| 21 | quaternary ammonium group transport (GO:0015697) | 5.71251345 |
| 22 | renal absorption (GO:0070293) | 5.49688323 |
| 23 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.48139874 |
| 24 | response to mercury ion (GO:0046689) | 5.42472249 |
| 25 | glutathione biosynthetic process (GO:0006750) | 5.40114240 |
| 26 | lipoprotein transport (GO:0042953) | 5.38723160 |
| 27 | aspartate family amino acid catabolic process (GO:0009068) | 5.28189740 |
| 28 | endocrine process (GO:0050886) | 5.21047884 |
| 29 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.21047884 |
| 30 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.21047884 |
| 31 | * excretion (GO:0007588) | 5.13752474 |
| 32 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.09296361 |
| 33 | diacylglycerol metabolic process (GO:0046339) | 5.00588210 |
| 34 | hormone catabolic process (GO:0042447) | 4.95078058 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.88668444 |
| 36 | trivalent inorganic anion homeostasis (GO:0072506) | 4.87307114 |
| 37 | phosphate ion homeostasis (GO:0055062) | 4.87307114 |
| 38 | serine family amino acid metabolic process (GO:0009069) | 4.82288932 |
| 39 | proline metabolic process (GO:0006560) | 4.80282283 |
| 40 | tricarboxylic acid metabolic process (GO:0072350) | 4.75749584 |
| 41 | regulation of systemic arterial blood pressure (GO:0003073) | 4.72001033 |
| 42 | regulation of cellular extravasation (GO:0002691) | 4.70440989 |
| 43 | plasma lipoprotein particle assembly (GO:0034377) | 4.68238028 |
| 44 | short-chain fatty acid metabolic process (GO:0046459) | 4.67738160 |
| 45 | NADH metabolic process (GO:0006734) | 4.64959621 |
| 46 | regulation of cGMP biosynthetic process (GO:0030826) | 4.63158702 |
| 47 | renal system process involved in regulation of blood volume (GO:0001977) | 4.58907680 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.56332852 |
| 49 | fructose metabolic process (GO:0006000) | 4.55344628 |
| 50 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.54969478 |
| 51 | polyol transport (GO:0015791) | 4.42359816 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 4.42306105 |
| 53 | positive regulation of pseudopodium assembly (GO:0031274) | 4.33671941 |
| 54 | peptide biosynthetic process (GO:0043043) | 4.33652144 |
| 55 | urea cycle (GO:0000050) | 4.31947514 |
| 56 | * vitamin transport (GO:0051180) | 4.28615258 |
| 57 | protein-lipid complex assembly (GO:0065005) | 4.28053165 |
| 58 | L-phenylalanine metabolic process (GO:0006558) | 4.25149248 |
| 59 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.25149248 |
| 60 | oligosaccharide catabolic process (GO:0009313) | 4.24633165 |
| 61 | amino-acid betaine transport (GO:0015838) | 4.24569947 |
| 62 | carnitine transport (GO:0015879) | 4.24569947 |
| 63 | peptide catabolic process (GO:0043171) | 4.22145406 |
| 64 | cellular modified amino acid catabolic process (GO:0042219) | 4.18462537 |
| 65 | urea metabolic process (GO:0019627) | 4.17960770 |
| 66 | sulfur compound transport (GO:0072348) | 4.17071607 |
| 67 | intestinal absorption (GO:0050892) | 4.15977627 |
| 68 | antibacterial humoral response (GO:0019731) | 4.15699873 |
| 69 | serine family amino acid biosynthetic process (GO:0009070) | 4.14959288 |
| 70 | adhesion of symbiont to host cell (GO:0044650) | 4.12863769 |
| 71 | virion attachment to host cell (GO:0019062) | 4.12863769 |
| 72 | antimicrobial humoral response (GO:0019730) | 4.08291613 |
| 73 | flavonoid metabolic process (GO:0009812) | 4.04309007 |
| 74 | vitamin transmembrane transport (GO:0035461) | 4.03497006 |
| 75 | bile acid and bile salt transport (GO:0015721) | 4.02312681 |
| 76 | peptide hormone processing (GO:0016486) | 4.01394013 |
| 77 | metanephric tubule development (GO:0072170) | 3.97049351 |
| 78 | metanephric nephron tubule development (GO:0072234) | 3.97049351 |
| 79 | regulation of cholesterol esterification (GO:0010872) | 3.96057338 |
| 80 | amino-acid betaine metabolic process (GO:0006577) | 3.93154345 |
| 81 | nitrogen cycle metabolic process (GO:0071941) | 3.91598526 |
| 82 | 2-oxoglutarate metabolic process (GO:0006103) | 3.90660744 |
| 83 | tryptophan catabolic process (GO:0006569) | 3.90498602 |
| 84 | indole-containing compound catabolic process (GO:0042436) | 3.90498602 |
| 85 | indolalkylamine catabolic process (GO:0046218) | 3.90498602 |
| 86 | cellular glucuronidation (GO:0052695) | 3.90470735 |
| 87 | phospholipid efflux (GO:0033700) | 3.90189252 |
| 88 | glucuronate metabolic process (GO:0019585) | 3.89590175 |
| 89 | uronic acid metabolic process (GO:0006063) | 3.89590175 |
| 90 | regulation of pseudopodium assembly (GO:0031272) | 3.87809658 |
| 91 | glutamate metabolic process (GO:0006536) | 3.85473815 |
| 92 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.84760238 |
| 93 | regulation of cGMP metabolic process (GO:0030823) | 3.83786104 |
| 94 | glycoside metabolic process (GO:0016137) | 3.82683668 |
| 95 | aromatic amino acid family catabolic process (GO:0009074) | 3.81729669 |
| 96 | branched-chain amino acid metabolic process (GO:0009081) | 3.81026431 |
| 97 | response to phenylpropanoid (GO:0080184) | 3.78632249 |
| 98 | regulation of vitamin metabolic process (GO:0030656) | 3.76177410 |
| 99 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.74430072 |
| 100 | glutathione derivative metabolic process (GO:1901685) | 3.70981200 |
| 101 | glutathione derivative biosynthetic process (GO:1901687) | 3.70981200 |
| 102 | alditol metabolic process (GO:0019400) | 3.69100769 |
| 103 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.68388431 |
| 104 | L-phenylalanine catabolic process (GO:0006559) | 3.68388431 |
| 105 | toxin transport (GO:1901998) | 3.68308104 |
| 106 | positive regulation of respiratory burst (GO:0060267) | 3.67039178 |
| 107 | glutathione metabolic process (GO:0006749) | 3.65279910 |
| 108 | cGMP-mediated signaling (GO:0019934) | 3.64790848 |
| 109 | alkaloid metabolic process (GO:0009820) | 3.63035839 |
| 110 | adhesion of symbiont to host (GO:0044406) | 3.62751650 |
| 111 | cellular response to nitric oxide (GO:0071732) | 3.62284712 |
| 112 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.61770691 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.61770691 |
| 114 | metanephric nephron epithelium development (GO:0072243) | 3.61332344 |
| 115 | tryptophan metabolic process (GO:0006568) | 3.60753369 |
| 116 | folic acid metabolic process (GO:0046655) | 3.60404936 |
| 117 | cellular ketone body metabolic process (GO:0046950) | 3.59505964 |
| 118 | digestion (GO:0007586) | 3.59304798 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 3.58958131 |
| 120 | angiotensin maturation (GO:0002003) | 3.56055811 |
| 121 | fatty acid beta-oxidation (GO:0006635) | 3.56020793 |
| 122 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.53801835 |
| 123 | glycolipid catabolic process (GO:0019377) | 3.52858546 |
| 124 | glycosphingolipid catabolic process (GO:0046479) | 3.51345209 |
| 125 | drug metabolic process (GO:0017144) | 3.50720305 |
| 126 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.50693311 |
| 127 | tricarboxylic acid cycle (GO:0006099) | 3.49818332 |
| 128 | ethanol oxidation (GO:0006069) | 3.48176897 |
| 129 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.46211368 |
| 130 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.44236481 |
| 131 | carnitine metabolic process (GO:0009437) | 3.42500518 |
| 132 | plasma lipoprotein particle organization (GO:0071827) | 3.37578234 |
| 133 | response to nitric oxide (GO:0071731) | 3.37336257 |
| 134 | positive regulation of lipid catabolic process (GO:0050996) | 3.37102781 |
| 135 | response to parathyroid hormone (GO:0071107) | 3.36774804 |
| 136 | fat-soluble vitamin metabolic process (GO:0006775) | 3.35820894 |
| 137 | transepithelial transport (GO:0070633) | 3.35541838 |
| 138 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.34760472 |
| 139 | glycerol metabolic process (GO:0006071) | 3.33901424 |
| 140 | acetyl-CoA metabolic process (GO:0006084) | 3.33817502 |
| 141 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.33676020 |
| 142 | fatty acid oxidation (GO:0019395) | 3.33259320 |
| 143 | protein-lipid complex remodeling (GO:0034368) | 3.31471093 |
| 144 | macromolecular complex remodeling (GO:0034367) | 3.31471093 |
| 145 | plasma lipoprotein particle remodeling (GO:0034369) | 3.31471093 |
| 146 | cellular amino acid catabolic process (GO:0009063) | 3.31246449 |
| 147 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.30659747 |
| 148 | actin filament depolymerization (GO:0030042) | 3.29817878 |
| 149 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.28872890 |
| 150 | regulation of cholesterol homeostasis (GO:2000188) | 3.28857601 |
| 151 | metanephric epithelium development (GO:0072207) | 3.26854527 |
| 152 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.25825813 |
| 153 | lipid oxidation (GO:0034440) | 3.25019758 |
| 154 | protein-lipid complex subunit organization (GO:0071825) | 3.23577994 |
| 155 | valine metabolic process (GO:0006573) | 3.23507916 |
| 156 | high-density lipoprotein particle remodeling (GO:0034375) | 3.22837615 |
| 157 | sulfur amino acid catabolic process (GO:0000098) | 3.21555882 |
| 158 | arginine metabolic process (GO:0006525) | 3.21219186 |
| 159 | sodium ion transport (GO:0006814) | 3.20469924 |
| 160 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.20027362 |
| 161 | dicarboxylic acid metabolic process (GO:0043648) | 3.19359074 |
| 162 | alpha-amino acid catabolic process (GO:1901606) | 3.19013526 |
| 163 | cellular response to reactive nitrogen species (GO:1902170) | 3.18076435 |
| 164 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.15702458 |
| 165 | kynurenine metabolic process (GO:0070189) | 3.14546096 |
| 166 | digestive system process (GO:0022600) | 3.14197431 |
| 167 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.12939496 |
| 168 | folic acid transport (GO:0015884) | 3.12710779 |
| 169 | vitamin biosynthetic process (GO:0009110) | 3.12176769 |
| 170 | leukotriene metabolic process (GO:0006691) | 3.11755895 |
| 171 | ATP synthesis coupled proton transport (GO:0015986) | 3.11536885 |
| 172 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.11536885 |
| 173 | cytidine catabolic process (GO:0006216) | 3.10075763 |
| 174 | cytidine deamination (GO:0009972) | 3.10075763 |
| 175 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.08491116 |
| 176 | glomerular filtration (GO:0003094) | 3.06105648 |
| 177 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.05953630 |
| 178 | drinking behavior (GO:0042756) | 3.04489443 |
| 179 | vitamin A metabolic process (GO:0006776) | 3.03201678 |
| 180 | transcytosis (GO:0045056) | 3.01191386 |
| 181 | bile acid metabolic process (GO:0008206) | 3.00486876 |
| 182 | sexual reproduction (GO:0019953) | 2.98762536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.58745387 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.25191652 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.15286602 |
| 4 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 4.01670571 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.72166177 |
| 6 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.44854959 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.43765175 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.23200885 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.15205989 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.12748121 |
| 11 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.99348684 |
| 12 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.84803625 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.84019598 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.77956323 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.69506429 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.54706784 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.44022911 |
| 18 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.25550114 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21881011 |
| 20 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.15000416 |
| 21 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.04070837 |
| 22 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.03506575 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97043607 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94420101 |
| 25 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.91870095 |
| 26 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.88083493 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80128253 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78382707 |
| 29 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.76623963 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74835399 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.73081963 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71459919 |
| 33 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.70198000 |
| 34 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.60211680 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.59226890 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59183298 |
| 37 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.58695812 |
| 38 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.51143813 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48157682 |
| 40 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.47393701 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.47272791 |
| 42 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.46172904 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45373193 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41283681 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38326194 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.38083393 |
| 47 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.36453296 |
| 48 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.36254395 |
| 49 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.35832029 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34719442 |
| 51 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31485524 |
| 52 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.31234645 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.30878622 |
| 54 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30672927 |
| 55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.28976681 |
| 56 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28339794 |
| 57 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24368941 |
| 58 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24016534 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.23441366 |
| 60 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.22382037 |
| 61 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.21922119 |
| 62 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21797053 |
| 63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21517003 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20683803 |
| 65 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.18586829 |
| 66 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.18263297 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.17931831 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17369576 |
| 69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17368860 |
| 70 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17202183 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16882414 |
| 72 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.16757489 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15835417 |
| 74 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15411252 |
| 75 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14437190 |
| 76 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.13311319 |
| 77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13229701 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12190808 |
| 79 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12081862 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.07885059 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07372487 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06664857 |
| 83 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.04985694 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04921488 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04753330 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04354987 |
| 87 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.03779084 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03456594 |
| 89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01548770 |
| 90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01493363 |
| 91 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.00300565 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00112559 |
| 93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99616396 |
| 94 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99152035 |
| 95 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98829020 |
| 96 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.98679664 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98521359 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97070118 |
| 99 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96896203 |
| 100 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.96152040 |
| 101 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95849365 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.95837362 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95732882 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94978616 |
| 105 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.94351755 |
| 106 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.93226262 |
| 107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92611170 |
| 108 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92506726 |
| 109 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92070492 |
| 110 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.92025752 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91613899 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91134628 |
| 113 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.91092459 |
| 114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90609280 |
| 115 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90367276 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89522030 |
| 117 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.89487512 |
| 118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88993902 |
| 119 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88944320 |
| 120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.88622301 |
| 121 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.88483516 |
| 122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88050748 |
| 123 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.87725174 |
| 124 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86235697 |
| 125 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.85264537 |
| 126 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85025283 |
| 127 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84657748 |
| 128 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84250755 |
| 129 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84101387 |
| 130 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83734953 |
| 131 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.83587409 |
| 132 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.82980294 |
| 133 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.82775095 |
| 134 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82718773 |
| 135 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.82365619 |
| 136 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82312898 |
| 137 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.80812246 |
| 138 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.78563458 |
| 139 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.77129894 |
| 140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76682935 |
| 141 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.76585503 |
| 142 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.76289290 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75972607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.25318467 |
| 2 | MP0004019_abnormal_vitamin_homeostasis | 5.40029974 |
| 3 | MP0004043_abnormal_pH_regulation | 5.11781703 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.67079329 |
| 5 | MP0005332_abnormal_amino_acid | 4.28279509 |
| 6 | MP0009379_abnormal_foot_pigmentation | 4.00628702 |
| 7 | MP0009643_abnormal_urine_homeostasis | 3.49451119 |
| 8 | MP0005377_hearing/vestibular/ear_phenot | 3.39158469 |
| 9 | MP0003878_abnormal_ear_physiology | 3.39158469 |
| 10 | MP0001765_abnormal_ion_homeostasis | 3.24644028 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.97021936 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.93129461 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.92207910 |
| 14 | MP0003195_calcinosis | 2.70815762 |
| 15 | MP0005636_abnormal_mineral_homeostasis | 2.69233938 |
| 16 | MP0001756_abnormal_urination | 2.57417456 |
| 17 | MP0002136_abnormal_kidney_physiology | 2.54257175 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.50564637 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.49597605 |
| 20 | MP0005365_abnormal_bile_salt | 2.43918806 |
| 21 | MP0003252_abnormal_bile_duct | 2.26032286 |
| 22 | MP0005409_darkened_coat_color | 2.19698061 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 2.08777918 |
| 24 | MP0001958_emphysema | 1.98853280 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.92743521 |
| 26 | MP0000538_abnormal_urinary_bladder | 1.83534340 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.79835386 |
| 28 | MP0003868_abnormal_feces_composition | 1.67479457 |
| 29 | MP0005451_abnormal_body_composition | 1.54150950 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.35639727 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.34655515 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.31815130 |
| 33 | MP0001188_hyperpigmentation | 1.28369807 |
| 34 | MP0009840_abnormal_foam_cell | 1.27926334 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26980221 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.25542480 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.23864644 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.19373561 |
| 39 | MP0004885_abnormal_endolymph | 1.18467189 |
| 40 | MP0003186_abnormal_redox_activity | 1.16672526 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.15530920 |
| 42 | MP0002089_abnormal_postnatal_growth/wei | 1.13659408 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.11074255 |
| 44 | MP0001764_abnormal_homeostasis | 1.06355605 |
| 45 | MP0003879_abnormal_hair_cell | 1.05758716 |
| 46 | MP0002796_impaired_skin_barrier | 1.05389707 |
| 47 | MP0000537_abnormal_urethra_morphology | 1.01822479 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.01736527 |
| 49 | MP0004147_increased_porphyrin_level | 0.97906933 |
| 50 | MP0005448_abnormal_energy_balance | 0.95394178 |
| 51 | MP0002971_abnormal_brown_adipose | 0.94637206 |
| 52 | MP0000230_abnormal_systemic_arterial | 0.93127363 |
| 53 | MP0002822_catalepsy | 0.92630524 |
| 54 | MP0001845_abnormal_inflammatory_respons | 0.92475475 |
| 55 | MP0004272_abnormal_basement_membrane | 0.91993054 |
| 56 | MP0003315_abnormal_perineum_morphology | 0.91791586 |
| 57 | MP0005666_abnormal_adipose_tissue | 0.91266992 |
| 58 | MP0003283_abnormal_digestive_organ | 0.90996284 |
| 59 | MP0002135_abnormal_kidney_morphology | 0.89099806 |
| 60 | MP0003123_paternal_imprinting | 0.88858127 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 0.88259489 |
| 62 | MP0003718_maternal_effect | 0.87152669 |
| 63 | MP0003303_peritoneal_inflammation | 0.86448500 |
| 64 | MP0003436_decreased_susceptibility_to | 0.85956108 |
| 65 | MP0009785_altered_susceptibility_to | 0.83117111 |
| 66 | MP0004270_analgesia | 0.80570177 |
| 67 | MP0000566_synostosis | 0.80564700 |
| 68 | MP0001663_abnormal_digestive_system | 0.80497220 |
| 69 | MP0003941_abnormal_skin_development | 0.78553192 |
| 70 | MP0003638_abnormal_response/metabolism_ | 0.78507573 |
| 71 | MP0005025_abnormal_response_to | 0.76241206 |
| 72 | MP0009115_abnormal_fat_cell | 0.75966880 |
| 73 | MP0001664_abnormal_digestion | 0.75738261 |
| 74 | MP0000462_abnormal_digestive_system | 0.75695349 |
| 75 | MP0008469_abnormal_protein_level | 0.75634318 |
| 76 | MP0003724_increased_susceptibility_to | 0.75077854 |
| 77 | MP0005501_abnormal_skin_physiology | 0.74651575 |
| 78 | MP0005535_abnormal_body_temperature | 0.74612706 |
| 79 | MP0009642_abnormal_blood_homeostasis | 0.72190106 |
| 80 | MP0001501_abnormal_sleep_pattern | 0.71599970 |
| 81 | MP0005381_digestive/alimentary_phenotyp | 0.71164527 |
| 82 | MP0001485_abnormal_pinna_reflex | 0.70729489 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.69596016 |
| 84 | MP0001835_abnormal_antigen_presentation | 0.68819632 |
| 85 | MP0006035_abnormal_mitochondrial_morpho | 0.68302225 |
| 86 | MP0002166_altered_tumor_susceptibility | 0.67898572 |
| 87 | MP0002896_abnormal_bone_mineralization | 0.67324266 |
| 88 | MP0000609_abnormal_liver_physiology | 0.67214534 |
| 89 | MP0005387_immune_system_phenotype | 0.67092872 |
| 90 | MP0001790_abnormal_immune_system | 0.67092872 |
| 91 | MP0005395_other_phenotype | 0.66973660 |
| 92 | MP0000604_amyloidosis | 0.66227303 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 0.65444222 |
| 94 | MP0003329_amyloid_beta_deposits | 0.64906724 |
| 95 | MP0009333_abnormal_splenocyte_physiolog | 0.64402899 |
| 96 | MP0000477_abnormal_intestine_morphology | 0.64312316 |
| 97 | MP0000249_abnormal_blood_vessel | 0.63600679 |
| 98 | MP0008872_abnormal_physiological_respon | 0.62237695 |
| 99 | MP0003646_muscle_fatigue | 0.60945045 |
| 100 | MP0004947_skin_inflammation | 0.60636694 |
| 101 | MP0002098_abnormal_vibrissa_morphology | 0.58526507 |
| 102 | MP0002928_abnormal_bile_duct | 0.56455497 |
| 103 | MP0003866_abnormal_defecation | 0.55876258 |
| 104 | MP0000490_abnormal_crypts_of | 0.55308006 |
| 105 | MP0009764_decreased_sensitivity_to | 0.52856144 |
| 106 | MP0005334_abnormal_fat_pad | 0.52731976 |
| 107 | MP0006082_CNS_inflammation | 0.52033390 |
| 108 | MP0000678_abnormal_parathyroid_gland | 0.51728314 |
| 109 | MP0002168_other_aberrant_phenotype | 0.51463745 |
| 110 | MP0002148_abnormal_hypersensitivity_rea | 0.50483792 |
| 111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.49112345 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.47767285 |
| 113 | MP0008260_abnormal_autophagy | 0.46918759 |
| 114 | MP0004858_abnormal_nervous_system | 0.46514845 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.46258466 |
| 116 | MP0003953_abnormal_hormone_level | 0.45562004 |
| 117 | MP0004484_altered_response_of | 0.45133755 |
| 118 | MP0009672_abnormal_birth_weight | 0.44686808 |
| 119 | MP0000598_abnormal_liver_morphology | 0.42347864 |
| 120 | MP0005165_increased_susceptibility_to | 0.41211151 |
| 121 | MP0002078_abnormal_glucose_homeostasis | 0.41153200 |
| 122 | MP0010155_abnormal_intestine_physiology | 0.40688570 |
| 123 | MP0005670_abnormal_white_adipose | 0.40507437 |
| 124 | MP0000747_muscle_weakness | 0.39016033 |
| 125 | MP0002069_abnormal_eating/drinking_beha | 0.35494188 |
| 126 | MP0003183_abnormal_peptide_metabolism | 0.34217627 |
| 127 | MP0001661_extended_life_span | 0.34155554 |
| 128 | MP0003119_abnormal_digestive_system | 0.34016296 |
| 129 | MP0001873_stomach_inflammation | 0.33963802 |
| 130 | MP0003705_abnormal_hypodermis_morpholog | 0.33573040 |
| 131 | MP0001727_abnormal_embryo_implantation | 0.33042798 |
| 132 | MP0001963_abnormal_hearing_physiology | 0.32851176 |
| 133 | MP0001849_ear_inflammation | 0.31462323 |
| 134 | MP0005166_decreased_susceptibility_to | 0.31339057 |
| 135 | MP0008004_abnormal_stomach_pH | 0.30179772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 6.59405709 |
| 2 | Metabolic alkalosis (HP:0200114) | 6.54649910 |
| 3 | Gout (HP:0001997) | 6.44747983 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 6.14187207 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.08448026 |
| 6 | Hypomagnesemia (HP:0002917) | 5.98881035 |
| 7 | Polyuria (HP:0000103) | 5.89576414 |
| 8 | Abnormal urine output (HP:0012590) | 5.75157659 |
| 9 | Proximal tubulopathy (HP:0000114) | 5.69517543 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.68910429 |
| 11 | Abnormality of chloride homeostasis (HP:0011422) | 5.58531356 |
| 12 | Abnormality of renal excretion (HP:0011036) | 5.45194760 |
| 13 | Abnormality of magnesium homeostasis (HP:0004921) | 5.40241500 |
| 14 | Hyperglycinuria (HP:0003108) | 5.35311210 |
| 15 | Hyperuricemia (HP:0002149) | 4.89848588 |
| 16 | Increased purine levels (HP:0004368) | 4.89848588 |
| 17 | Chronic diarrhea (HP:0002028) | 4.85187776 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 4.80759003 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 4.79123606 |
| 20 | Polydipsia (HP:0001959) | 4.62026578 |
| 21 | Abnormal drinking behavior (HP:0030082) | 4.62026578 |
| 22 | Abnormality of purine metabolism (HP:0004352) | 4.37293942 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 4.32813111 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.32813111 |
| 25 | Alkalosis (HP:0001948) | 4.25745449 |
| 26 | Abnormality of urine glucose concentration (HP:0011016) | 4.16739296 |
| 27 | Glycosuria (HP:0003076) | 4.16739296 |
| 28 | Hypercalciuria (HP:0002150) | 4.13007698 |
| 29 | Abnormality of renin-angiotensin system (HP:0000847) | 4.11989705 |
| 30 | Renal salt wasting (HP:0000127) | 4.10567566 |
| 31 | Tetany (HP:0001281) | 4.08377021 |
| 32 | Fat malabsorption (HP:0002630) | 4.07012006 |
| 33 | Hyperaldosteronism (HP:0000859) | 4.03776462 |
| 34 | Hyperphosphaturia (HP:0003109) | 3.95832246 |
| 35 | Decreased circulating renin level (HP:0003351) | 3.76574464 |
| 36 | Generalized aminoaciduria (HP:0002909) | 3.74633510 |
| 37 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.68710815 |
| 38 | Abnormality of proline metabolism (HP:0010907) | 3.63892224 |
| 39 | Hydroxyprolinuria (HP:0003080) | 3.63892224 |
| 40 | Abnormal urine phosphate concentration (HP:0012599) | 3.59293895 |
| 41 | Delayed epiphyseal ossification (HP:0002663) | 3.53083444 |
| 42 | Acanthocytosis (HP:0001927) | 3.41680106 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.35864245 |
| 44 | Ketoacidosis (HP:0001993) | 3.34688977 |
| 45 | Malnutrition (HP:0004395) | 3.33585424 |
| 46 | Hemorrhage of the eye (HP:0011885) | 3.25280376 |
| 47 | Nephrolithiasis (HP:0000787) | 3.20724273 |
| 48 | Congenital sensorineural hearing impairment (HP:0008527) | 3.19815983 |
| 49 | Hypokalemia (HP:0002900) | 3.13514102 |
| 50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.11998631 |
| 51 | Abdominal distention (HP:0003270) | 3.11846864 |
| 52 | Pigmentary retinal degeneration (HP:0001146) | 3.10597804 |
| 53 | Renal tubular acidosis (HP:0001947) | 3.09692364 |
| 54 | Hyperglycinemia (HP:0002154) | 3.08657936 |
| 55 | Ketosis (HP:0001946) | 2.86182656 |
| 56 | Widely patent fontanelles and sutures (HP:0004492) | 2.84853183 |
| 57 | Hypophosphatemia (HP:0002148) | 2.77811093 |
| 58 | Nephrocalcinosis (HP:0000121) | 2.72273983 |
| 59 | Complement deficiency (HP:0004431) | 2.71859036 |
| 60 | Eczematoid dermatitis (HP:0000976) | 2.69966691 |
| 61 | Abnormality of complement system (HP:0005339) | 2.68976947 |
| 62 | Hyperparathyroidism (HP:0000843) | 2.68935349 |
| 63 | Steatorrhea (HP:0002570) | 2.67423082 |
| 64 | Villous atrophy (HP:0011473) | 2.65337795 |
| 65 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.65337795 |
| 66 | Glomerulonephritis (HP:0000099) | 2.65332438 |
| 67 | Dehydration (HP:0001944) | 2.63661430 |
| 68 | Posterior subcapsular cataract (HP:0007787) | 2.58452911 |
| 69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.56948157 |
| 70 | Hyperammonemia (HP:0001987) | 2.56030159 |
| 71 | Hypolipoproteinemia (HP:0010981) | 2.52690407 |
| 72 | Abnormality of potassium homeostasis (HP:0011042) | 2.50636268 |
| 73 | * Confusion (HP:0001289) | 2.48521908 |
| 74 | Vacuolated lymphocytes (HP:0001922) | 2.46051473 |
| 75 | Delayed CNS myelination (HP:0002188) | 2.45523579 |
| 76 | Rickets (HP:0002748) | 2.45289962 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.43995782 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43995782 |
| 79 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.42814675 |
| 80 | Focal segmental glomerulosclerosis (HP:0000097) | 2.40852198 |
| 81 | Ileus (HP:0002595) | 2.40560080 |
| 82 | Lethargy (HP:0001254) | 2.39359456 |
| 83 | Flat acetabular roof (HP:0003180) | 2.38657344 |
| 84 | * Abnormality of vitamin metabolism (HP:0100508) | 2.33405674 |
| 85 | Vascular calcification (HP:0004934) | 2.32943324 |
| 86 | Vomiting (HP:0002013) | 2.31072080 |
| 87 | Metabolic acidosis (HP:0001942) | 2.29659513 |
| 88 | Metaphyseal cupping (HP:0003021) | 2.26914778 |
| 89 | Nephritis (HP:0000123) | 2.26387387 |
| 90 | Abnormality of sodium homeostasis (HP:0010931) | 2.25691929 |
| 91 | Thin bony cortex (HP:0002753) | 2.20941229 |
| 92 | Hyponatremia (HP:0002902) | 2.20678115 |
| 93 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.20142017 |
| 94 | Cerebral palsy (HP:0100021) | 2.19276996 |
| 95 | Hyperphosphatemia (HP:0002905) | 2.17904769 |
| 96 | Renal tubular dysfunction (HP:0000124) | 2.17780116 |
| 97 | Nausea (HP:0002018) | 2.16456026 |
| 98 | Growth hormone excess (HP:0000845) | 2.15923364 |
| 99 | Abnormality of renal resorption (HP:0011038) | 2.14690870 |
| 100 | Abnormal tarsal ossification (HP:0008369) | 2.13815179 |
| 101 | Epidermoid cyst (HP:0200040) | 2.12918571 |
| 102 | Pancreatitis (HP:0001733) | 2.12795988 |
| 103 | Methylmalonic aciduria (HP:0012120) | 2.10316029 |
| 104 | Subcapsular cataract (HP:0000523) | 2.06418328 |
| 105 | Potter facies (HP:0002009) | 2.06131154 |
| 106 | Facial shape deformation (HP:0011334) | 2.06131154 |
| 107 | Right ventricular cardiomyopathy (HP:0011663) | 2.05170163 |
| 108 | Protuberant abdomen (HP:0001538) | 2.04119413 |
| 109 | Enlarged kidneys (HP:0000105) | 2.02864285 |
| 110 | Cardiovascular calcification (HP:0011915) | 2.01999090 |
| 111 | Pili torti (HP:0003777) | 2.00883384 |
| 112 | Bicornuate uterus (HP:0000813) | 1.99772880 |
| 113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99512654 |
| 114 | Gingivitis (HP:0000230) | 1.98569583 |
| 115 | Adrenal overactivity (HP:0002717) | 1.96229505 |
| 116 | Gastrointestinal dysmotility (HP:0002579) | 1.96205227 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.96124747 |
| 118 | Abnormal glucose tolerance (HP:0001952) | 1.95414850 |
| 119 | Late onset (HP:0003584) | 1.94172678 |
| 120 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.93711474 |
| 121 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.90391632 |
| 122 | Acute encephalopathy (HP:0006846) | 1.89681779 |
| 123 | * Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.89538072 |
| 124 | Irritability (HP:0000737) | 1.87580131 |
| 125 | Hypoglycemic coma (HP:0001325) | 1.86742320 |
| 126 | Glomerulosclerosis (HP:0000096) | 1.84926044 |
| 127 | Metaphyseal irregularity (HP:0003025) | 1.83626170 |
| 128 | Xanthomatosis (HP:0000991) | 1.83561543 |
| 129 | Intrahepatic cholestasis (HP:0001406) | 1.82494654 |
| 130 | Abnormal hair laboratory examination (HP:0003328) | 1.82412137 |
| 131 | Abnormality of serum amino acid levels (HP:0003112) | 1.81270550 |
| 132 | Abnormality of the costochondral junction (HP:0000919) | 1.79320499 |
| 133 | Multiple lipomas (HP:0001012) | 1.78784687 |
| 134 | Wide cranial sutures (HP:0010537) | 1.78485846 |
| 135 | Petechiae (HP:0000967) | 1.78148575 |
| 136 | Pustule (HP:0200039) | 1.75906133 |
| 137 | Abnormality of carpal bone ossification (HP:0006257) | 1.75484335 |
| 138 | * Abnormality of vitamin B metabolism (HP:0004340) | 1.74962763 |
| 139 | Conjugated hyperbilirubinemia (HP:0002908) | 1.74724501 |
| 140 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74640855 |
| 141 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.71721428 |
| 142 | Tubular atrophy (HP:0000092) | 1.68545962 |
| 143 | Hypotension (HP:0002615) | 1.68387702 |
| 144 | Chondrocalcinosis (HP:0000934) | 1.64164188 |
| 145 | Enlarged epiphyses (HP:0010580) | 1.63772999 |
| 146 | Tubulointerstitial fibrosis (HP:0005576) | 1.63762487 |
| 147 | Sensorimotor neuropathy (HP:0007141) | 1.62268196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 7.80902900 |
| 2 | WNK3 | 7.01006523 |
| 3 | ACVR1B | 6.64352536 |
| 4 | OXSR1 | 6.41721916 |
| 5 | ERN1 | 5.33419542 |
| 6 | STK39 | 3.58975474 |
| 7 | STK38L | 2.98961923 |
| 8 | NME1 | 2.78602453 |
| 9 | MST4 | 2.71718978 |
| 10 | BCKDK | 2.50168837 |
| 11 | PDK4 | 2.33107138 |
| 12 | PDK3 | 2.33107138 |
| 13 | NEK1 | 2.32967615 |
| 14 | GRK6 | 2.09597679 |
| 15 | MAP4K1 | 1.95041343 |
| 16 | PIK3CA | 1.73101467 |
| 17 | PDK2 | 1.61877492 |
| 18 | TYK2 | 1.58931172 |
| 19 | FRK | 1.58728753 |
| 20 | MST1R | 1.52739187 |
| 21 | DDR2 | 1.46363251 |
| 22 | STK38 | 1.40048799 |
| 23 | RIPK4 | 1.39384428 |
| 24 | SGK223 | 1.38546322 |
| 25 | SGK494 | 1.38546322 |
| 26 | MAP3K3 | 1.38346739 |
| 27 | PRPF4B | 1.34715364 |
| 28 | EPHA3 | 1.29465259 |
| 29 | MATK | 1.27927544 |
| 30 | TTK | 1.26779341 |
| 31 | MAP3K1 | 1.25708929 |
| 32 | EPHB1 | 1.22269095 |
| 33 | WNK1 | 1.20945033 |
| 34 | PRKCI | 1.20704946 |
| 35 | FGFR3 | 1.14482692 |
| 36 | MAP3K11 | 1.12015045 |
| 37 | PAK4 | 1.11767505 |
| 38 | TRIB3 | 1.10321300 |
| 39 | CDC42BPA | 1.07393802 |
| 40 | SMG1 | 1.04377877 |
| 41 | SCYL2 | 1.02553854 |
| 42 | NME2 | 0.94156301 |
| 43 | STK24 | 0.93157927 |
| 44 | ERBB2 | 0.91228488 |
| 45 | EPHA2 | 0.91104577 |
| 46 | LRRK2 | 0.91088344 |
| 47 | MAP2K2 | 0.85673796 |
| 48 | LMTK2 | 0.83812970 |
| 49 | TBK1 | 0.82097744 |
| 50 | NEK2 | 0.80297107 |
| 51 | SIK1 | 0.77225730 |
| 52 | BUB1 | 0.77164951 |
| 53 | STK10 | 0.76269176 |
| 54 | PRKG2 | 0.75968542 |
| 55 | MAP3K2 | 0.74881899 |
| 56 | PTK2 | 0.73811534 |
| 57 | IRAK3 | 0.68401815 |
| 58 | GSK3A | 0.67141402 |
| 59 | TAOK1 | 0.66630694 |
| 60 | KSR2 | 0.59337350 |
| 61 | TNIK | 0.58685112 |
| 62 | PTK6 | 0.57912938 |
| 63 | PAK3 | 0.57395893 |
| 64 | MAPK11 | 0.57068421 |
| 65 | MAP3K10 | 0.57007926 |
| 66 | TESK1 | 0.56511117 |
| 67 | IKBKE | 0.56507683 |
| 68 | NLK | 0.54784880 |
| 69 | PDPK1 | 0.54225325 |
| 70 | BRAF | 0.53889963 |
| 71 | ZAP70 | 0.53431995 |
| 72 | MAP3K8 | 0.53003513 |
| 73 | CSF1R | 0.51811023 |
| 74 | SGK2 | 0.51345868 |
| 75 | KSR1 | 0.51158009 |
| 76 | SGK3 | 0.49931570 |
| 77 | CSK | 0.49248781 |
| 78 | RIPK1 | 0.48881822 |
| 79 | AKT2 | 0.47472212 |
| 80 | FER | 0.46960316 |
| 81 | SRC | 0.46794852 |
| 82 | AKT3 | 0.46174665 |
| 83 | ICK | 0.46149448 |
| 84 | LIMK1 | 0.45256903 |
| 85 | PDGFRA | 0.45049607 |
| 86 | MAP3K9 | 0.44721236 |
| 87 | RET | 0.44607561 |
| 88 | STK11 | 0.43702773 |
| 89 | FGFR4 | 0.43332038 |
| 90 | MAP2K6 | 0.43146429 |
| 91 | BMX | 0.41808056 |
| 92 | FYN | 0.41760186 |
| 93 | CAMK2D | 0.41300697 |
| 94 | TESK2 | 0.40688170 |
| 95 | PRKAA1 | 0.40450630 |
| 96 | MAP3K14 | 0.40056730 |
| 97 | EPHB2 | 0.38146696 |
| 98 | SGK1 | 0.38001735 |
| 99 | ITK | 0.37031003 |
| 100 | ARAF | 0.36685804 |
| 101 | LATS1 | 0.36466055 |
| 102 | IRAK1 | 0.36020958 |
| 103 | PINK1 | 0.35781775 |
| 104 | JAK1 | 0.34502911 |
| 105 | MARK1 | 0.34042449 |
| 106 | MET | 0.33998906 |
| 107 | MINK1 | 0.33617375 |
| 108 | JAK2 | 0.33062785 |
| 109 | PRKCZ | 0.32436504 |
| 110 | IRAK4 | 0.32120279 |
| 111 | PDK1 | 0.31569734 |
| 112 | DYRK1B | 0.31044552 |
| 113 | LYN | 0.29939344 |
| 114 | PRKAA2 | 0.29869219 |
| 115 | EPHA4 | 0.29678024 |
| 116 | PRKCQ | 0.29498480 |
| 117 | BTK | 0.29182084 |
| 118 | JAK3 | 0.28423834 |
| 119 | EIF2AK1 | 0.28308349 |
| 120 | SYK | 0.28303821 |
| 121 | RPS6KA2 | 0.28207772 |
| 122 | ABL2 | 0.26852075 |
| 123 | MYLK | 0.26789741 |
| 124 | AURKA | 0.26687884 |
| 125 | GRK1 | 0.26108523 |
| 126 | MAP2K1 | 0.25609195 |
| 127 | MAP3K12 | 0.25387171 |
| 128 | KDR | 0.23798713 |
| 129 | ERBB4 | 0.23536559 |
| 130 | MAPKAPK2 | 0.22448614 |
| 131 | RPS6KC1 | 0.22239292 |
| 132 | RPS6KL1 | 0.22239292 |
| 133 | LCK | 0.22100958 |
| 134 | PRKCA | 0.21521623 |
| 135 | PAK1 | 0.21457333 |
| 136 | TIE1 | 0.21025830 |
| 137 | MARK3 | 0.20865183 |
| 138 | PIM1 | 0.20786934 |
| 139 | MAP2K3 | 0.19002752 |
| 140 | MAP2K4 | 0.18996354 |
| 141 | STK16 | 0.18258458 |
| 142 | MAP3K7 | 0.16583936 |
| 143 | DYRK3 | 0.16557853 |
| 144 | LATS2 | 0.15167789 |
| 145 | PRKACG | 0.14955161 |
| 146 | CAMK2G | 0.14830290 |
| 147 | PRKCD | 0.14411885 |
| 148 | CSNK1E | 0.14284780 |
| 149 | CSNK1A1 | 0.14203862 |
| 150 | PRKCG | 0.11318133 |
| 151 | PRKACA | 0.08966166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.88474830 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.34978839 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.22409927 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18388719 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.10979497 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.93802296 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.84980825 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.79958212 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.49194823 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.47328647 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43979182 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.42054706 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.35905119 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11728442 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02683805 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01448090 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92757194 |
| 18 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.92657066 |
| 19 | Mineral absorption_Homo sapiens_hsa04978 | 1.91785387 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.91750174 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.86243065 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.84161519 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.82413536 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.81658495 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.78811723 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.76960517 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71165663 |
| 28 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.68149750 |
| 29 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.61317787 |
| 30 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.55279676 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.54975758 |
| 32 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.54219692 |
| 33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.51018120 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49320116 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48134550 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.40091230 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.39074617 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37040396 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.30917469 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28750504 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.28732417 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28019436 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15483501 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13886162 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11028693 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10436234 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10308640 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09398195 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07466623 |
| 50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04709935 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.00447721 |
| 52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.99403538 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97599781 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96077969 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.96028701 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94922612 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.92455798 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91795425 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91582127 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90993159 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.89830206 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89411065 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86236973 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85299133 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.83983795 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82281819 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80272373 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74766643 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69352307 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69097286 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65886148 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65765872 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58990581 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57480968 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.56219402 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55611510 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53428969 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52925715 |
| 79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50457944 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49305347 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48426907 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46094752 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45780973 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44637407 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43628400 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43568072 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43429668 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41856777 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40609091 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40569813 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39548226 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.39125052 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38236103 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36926060 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36707436 |
| 96 | Leishmaniasis_Homo sapiens_hsa05140 | 0.35924692 |
| 97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33179809 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.32441381 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31523840 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.31263723 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.30781953 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.25818584 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.23025886 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22701507 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20314682 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.20207481 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.19904488 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.18062226 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.17406819 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16852133 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.16631217 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.14652751 |
| 113 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.12084535 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.12034599 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.11349559 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.11254294 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09895630 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.09446135 |
| 119 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.07737014 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.07616737 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.07593249 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.06251824 |
| 123 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.05234324 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.04894178 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.04664873 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.04561039 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.03549559 |
| 128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.02075732 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.00204499 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0156022 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0138323 |

